Filing Details

Accession Number:
0001181431-11-047044
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-25 18:00:10
Reporting Period:
2011-08-23
Filing Date:
2011-08-25
Accepted Time:
2011-08-25 18:00:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820096 Perrigo Co PRGO Pharmaceutical Preparations (2834) 382799573
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1398274 Sharon Kochan C/O Perrigo Company
515 Eastern Avenue
Allegan MI 49010
Executive Vp U.s. Generics No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-08-23 1,434 $88.00 2,991 No 4 S Direct
Common Stock Acquisiton 2011-08-23 2,500 $15.47 5,491 No 4 M Direct
Common Stock Disposition 2011-08-23 2,500 $90.00 2,991 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option Right to Buy Acquisiton 2011-08-23 1,789 $0.00 1,789 $90.65
Common Stock Employee Stock Option Right to Buy Acquisiton 2011-08-23 1,789 $0.00 1,789 $90.65
Common Stock Employee Stock Option Right to Buy Acquisiton 2011-08-23 1,789 $0.00 1,789 $90.65
Common Stock Restricted Stock Units Acquisiton 2011-08-23 1,324 $0.00 1,324 $0.00
Common Stock Employee Stock Option Right to Buy Disposition 2011-08-23 2,500 $0.00 2,500 $15.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,789 2012-08-23 2021-08-23 No 4 A Direct
1,789 2013-08-23 2021-08-23 No 4 A Direct
1,789 2014-08-23 2021-08-23 No 4 A Direct
1,324 2014-08-23 2014-08-23 No 4 A Direct
0 2011-08-16 2016-08-16 No 4 M Direct
Footnotes
  1. Each Restricted Stock Unit represents a contingent right to receive one share of Perrigo Company common stock.
  2. Restricted Stock Units awarded Mr. Kochan in his capacity as Executive VP U.S. Generics, pursuant to the 2008 Long-Term Incentive Plan.